Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.0034 USD
Change Today +0.0002 / 6.25%
Volume 3.9M
As of 8:10 PM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mike Tomas

Chief Executive Officer, President, Chief Financial Officer, Director and Member of Advisory Board,Bioheart, Inc.
AgeTotal Calculated CompensationThis person is connected to 78 board members in 7 different organizations across 7 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Mike Tomas has been the Chief Executive Officer and President of Bioheart, Inc. since June 18, 2010 and serves as its Principal Financial Officer and Principal Accounting Officer. Mr. Tomas serves as the Vice President of Corporate Affairs of Pharmed Group. He serves as the Chief Strategic Officer of Total Home Health Inc. Mr. Tomas serves as the Chairman of Eugenio Pino & Family Global Entrepreneurship Center at Florida International University. Mr. Tomas has been ...

Read Full Background

Corporate Headquarters*

13794 NW 4th Street
Sunrise, Florida 33325

United States

Phone: 954-835-1500
Fax: 954-845-9976

Board Members Memberships*

Chief Strategic Officer and Member of The Board of Directors
Chief Executive Officer, President, Chief Financial Officer, Director and Member of Advisory Board


MBA 2000
University of Miami
Associate's Degree
Miami Dade College
BA 1990
Florida International University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$1,266,586

Stock Options*

Exercisable Options1,775,000
Unexercisable Options12,125,000
Total Number of Options13,900,000

Total Compensation*

Total Annual Cash Compensation$1,266,586
Total Short Term Compensation$1,266,586
Total Calculated Compensation$1,860,785
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BHRT:US $0.00 USD +0.0002


Michael D. West Ph.D.Chief Executive Officer, President and Director
BioTime, Inc.
Robin C. Stracey Chief Executive Officer and Director
Cesca Therapeutics Inc.
Robert L. Parkinson Jr.Chairman, Chief Executive Officer and President
Baxter International Inc.
Martin M. McGlynn Chief Executive Officer, Director, Member of Strategic Transactions Committee, Chief Executive Officer of Stemcells California Inc and President of Stemcells California Inc
StemCells Inc.
Andrey Semechkin Ph.D.Co-Chairman and Chief Executive Officer
International Stem Cell Corporation
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOHEART INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at